Literature DB >> 3174735

Behavior of monkeys during opiate withdrawal and locus coeruleus stimulation.

S J Grant1, Y H Huang, D E Redmond.   

Abstract

The noradrenergic nucleus locus coeruleus (LC) has been implicated in morphine withdrawal. The behavioral effects of opiate antagonist-precipitated morphine withdrawal in chair-restrained Macaca arctoides were therefore compared with LC electrical field stimulation. Both continuous LC stimulation and administration of low doses of naloxone to morphine pellet implanted monkeys produced a significant increase in the same group of behaviors reported previously to follow activation of the LC, without significant increases in general activity or distress behaviors. Signs of autonomic hyperactivity and distress were observed at high doses of naloxone, but not during LC stimulation. Monkeys which had not received morphine treatment did not specifically increased during low intensity LC stimulation is also selectively increased during naloxone-precipitated morphine withdrawal. These data are consistent with and suggest a behavioral consequence of the interactions of opioids with the LC reported at the molecular, intracellular, and cellular level.

Entities:  

Mesh:

Year:  1988        PMID: 3174735     DOI: 10.1016/0091-3057(88)90419-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  10 in total

1.  Increased opioid dependence in a mouse model of panic disorder.

Authors:  Xavier Gallego; Patricia Murtra; Teresa Zamalloa; Josep Maria Canals; Joseba Pineda; Alejandro Amador-Arjona; Rafael Maldonado; Mara Dierssen
Journal:  Front Behav Neurosci       Date:  2010-02-22       Impact factor: 3.558

2.  Decreases in endogenous opioid peptides in the rat medullo-coerulear pathway after chronic morphine treatment.

Authors:  E J Van Bockstaele; J Peoples; A S Menko; K McHugh; G Drolet
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

Review 3.  Second messenger and protein phosphorylation mechanisms underlying opiate addiction: studies in the rat locus coeruleus.

Authors:  X Guitart; E J Nestler
Journal:  Neurochem Res       Date:  1993-01       Impact factor: 3.996

4.  Lateral habenular norepinephrine contributes to states of arousal and anxiety in male rats.

Authors:  Erin M Purvis; Adam K Klein; Aaron Ettenberg
Journal:  Behav Brain Res       Date:  2018-03-09       Impact factor: 3.332

5.  Descending facilitatory pathways from the rostroventromedial medulla mediate naloxone-precipitated withdrawal in morphine-dependent rats.

Authors:  Louis P Vera-Portocarrero; Michael H Ossipov; Josephine Lai; Tamara King; Frank Porreca
Journal:  J Pain       Date:  2011-02-26       Impact factor: 5.820

Review 6.  Neuroadaptive responses in brainstem noradrenergic nuclei following chronic morphine exposure.

Authors:  E J Van Bockstaele; A S Menko; G Drolet
Journal:  Mol Neurobiol       Date:  2001 Apr-Jun       Impact factor: 5.590

7.  Evaluation of n-hexane extract of Viola betonicifolia for its neuropharmacological properties.

Authors:  Naveed Muhammad; Muhammad Saeed; Haroon Khan; Ikramul Haq
Journal:  J Nat Med       Date:  2012-02-23       Impact factor: 2.343

8.  Effects of naloxone-precipitated withdrawal after a single dose of morphine on catecholamine concentrations in guinea-pig brain.

Authors:  P J Brent; L A Chahl
Journal:  Neurochem Res       Date:  1991-05       Impact factor: 3.996

9.  Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal.

Authors:  S Numan; S B Lane-Ladd; L Zhang; K H Lundgren; D S Russell; K B Seroogy; E J Nestler
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

10.  Low dose naltrexone administration in morphine dependent rats attenuates withdrawal-induced norepinephrine efflux in forebrain.

Authors:  Elisabeth J Van Bockstaele; Yaping Qian; Robert C Sterling; Michelle E Page
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-03-25       Impact factor: 5.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.